130 related articles for article (PubMed ID: 12696176)
21. Fatal hepatotoxicity associated with troglitazone.
Vella A; de Groen PC; Dinneen SF
Ann Intern Med; 1998 Dec; 129(12):1080. PubMed ID: 9867776
[No Abstract] [Full Text] [Related]
22. Hepatotoxicity of the thiazolidinediones.
Tolman KG; Chandramouli J
Clin Liver Dis; 2003 May; 7(2):369-79, vi. PubMed ID: 12879989
[TBL] [Abstract][Full Text] [Related]
23. Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone.
Gitlin N; Julie NL; Spurr CL; Lim KN; Juarbe HM
Ann Intern Med; 1998 Jul; 129(1):36-8. PubMed ID: 9652997
[No Abstract] [Full Text] [Related]
24. Troglitazone-associated hepatic failure.
Booth AM; Caldwell SH; Iezzoni JC
Am J Gastroenterol; 2000 Feb; 95(2):557-8. PubMed ID: 10685776
[No Abstract] [Full Text] [Related]
25. Troglitazone-induced fulminant hepatitis: report of a case with autopsy findings.
Li H; Heller DS; Leevy CB; Zierer KG; Klein KM
J Diabetes Complications; 2000; 14(3):175-7. PubMed ID: 10989325
[TBL] [Abstract][Full Text] [Related]
26. Thiazolidinediones in diabetes: current status and future outlook.
Camp HS
Curr Opin Investig Drugs; 2003 Apr; 4(4):406-11. PubMed ID: 12808879
[TBL] [Abstract][Full Text] [Related]
27. Thiazolidinedione hepatotoxicity: a class effect?
Tolman KG
Int J Clin Pract Suppl; 2000 Oct; (113):29-34. PubMed ID: 11965828
[TBL] [Abstract][Full Text] [Related]
28. A novel antidiabetic drug, troglitazone--reason for hope and concern.
Imura H
N Engl J Med; 1998 Mar; 338(13):908-9. PubMed ID: 9516229
[No Abstract] [Full Text] [Related]
29. Pioglitazone-associated fulminant hepatic failure.
Chase MP; Yarze JC
Am J Gastroenterol; 2002 Feb; 97(2):502-3. PubMed ID: 11866308
[No Abstract] [Full Text] [Related]
30. Pioglitazone (Actos).
Med Lett Drugs Ther; 1999 Nov; 41(1066):112. PubMed ID: 10987011
[No Abstract] [Full Text] [Related]
31. Effects of pioglitazone on diabetes-related outcomes in Hispanic patients.
Jun JK; Gong WC; Mathur R
Am J Health Syst Pharm; 2003 Mar; 60(5):469-73. PubMed ID: 12635453
[No Abstract] [Full Text] [Related]
32. [Pioglitazone-induced acute severe hepatitis].
Arotçarena R; Bigué JP; Etcharry F; Pariente A
Gastroenterol Clin Biol; 2004; 28(6-7 Pt 1):610-1. PubMed ID: 15243398
[No Abstract] [Full Text] [Related]
33. Pioglitazone and rosiglitazone for diabetes.
Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
[TBL] [Abstract][Full Text] [Related]
34. Company played down drug's risks, report says.
Gottlieb S
BMJ; 2001 Mar; 322(7288):696. PubMed ID: 11264205
[No Abstract] [Full Text] [Related]
35. Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group.
Einhorn D; Rendell M; Rosenzweig J; Egan JW; Mathisen AL; Schneider RL
Clin Ther; 2000 Dec; 22(12):1395-409. PubMed ID: 11192132
[TBL] [Abstract][Full Text] [Related]
36. [New development in diabetes therapy. 35th Annual Meeting of the German Diabetes Society, Munich, May 5-June 3, 2000].
Stiefelhagen P
Internist (Berl); 2000 Sep; 41(9):930-2. PubMed ID: 11041699
[No Abstract] [Full Text] [Related]
37. Actos (pioglitazone HCL) provides a safe, effective alternative for patients formerly taking Rezulin.
Diabetes Technol Ther; 2000; 2(2):290-1. PubMed ID: 11469274
[No Abstract] [Full Text] [Related]
38. Lessons from the glitazones: a story of drug development.
Gale EA
Lancet; 2001 Jun; 357(9271):1870-5. PubMed ID: 11410214
[TBL] [Abstract][Full Text] [Related]
39. [Clinical efficacy of Pioglitazone (AD-4833)].
Kaneko T; Baba S
Nihon Rinsho; 1997 Nov; 55 Suppl():142-6. PubMed ID: 9434458
[No Abstract] [Full Text] [Related]
40. [The development of thiazolidinedione drugs as anti-diabetic agents].
Kuzuya T
Nihon Rinsho; 2000 Feb; 58(2):364-9. PubMed ID: 10707559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]